Skip to content
Home/Companies/MedTech/LePure

LePure

MedTech·China·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns LePure?

LePure is a Chinese MedTech company, currently owned by Novo Holdings since 2022.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth

Key facts

HQChina
SectorMedTech
StatusActive

More from Novo Holdings Growth Investments

Other portfolio companies in the same fund.

Surya Hospitals
Active
HealthcareIndia· 2026
Phasecraft
Phasecraft
Active
Deep TechUK· 2025
AvenCell
Active
BiotechUS· 2024
Cleveland Diagnostics
Active
MedTechUS· 2024
Convergent
Active
BiotechUS· 2024
Medi Assist
Active
HealthTechIndia· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns LePure?

LePure is currently owned by Novo Holdings, through Novo Holdings Growth Investments, since 2022.

When did Novo Holdings acquire LePure?

Novo Holdings acquired LePure in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue